Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to compare a medicine called pralsetinib with standard-of-care chemotherapy treatments in people with non-small cell lung cancer (NSCLC)

    AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive, Metastatic NSCLC

    • Cancer
    • Tumor
    • Neoplasms
    • Respiratory Tract Neoplasms
    • Lung Cancer
    • RET-fusion Non Small Cell Lung Cancer
    • Germ Cell and Embryonal Neoplasms
    • Non-Small Cell Lung Cancer (NSCLC)
    • Lung Neoplasm
    • Non Small Cell Lung Carcinoma
    • Carcinoma
    • Adenocarcinoma
    • Bronchogenic Carcinoma
    • Nerve Tissue Neoplasms
    • Thoracic Neoplasms
    • Head and Neck Cancer
    • Head and Neck Neoplasms

    For the latest version of this information please go to www.forpatients.roche.com